Herbalife Ltd.
HLF
$6.95
-$0.11-1.56%
NYSE
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Net Income | 280.40M | 254.30M | 86.60M | 82.00M | 137.20M |
Total Depreciation and Amortization | 122.90M | 121.40M | 120.60M | 118.40M | 114.90M |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | -115.30M | -122.80M | 54.50M | 46.80M | 22.40M |
Change in Net Operating Assets | -16.20M | 32.50M | 50.20M | 44.80M | 50.60M |
Cash from Operations | 271.80M | 285.40M | 311.90M | 292.00M | 325.10M |
Capital Expenditure | -107.40M | -122.00M | -131.60M | -135.60M | -137.60M |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 36.80M | 37.40M | 37.40M | 300.00K | 200.00K |
Cash from Investing | -70.60M | -84.60M | -94.20M | -135.30M | -137.40M |
Total Debt Issued | 2.08B | 2.17B | 1.92B | 1.88B | 305.40M |
Total Debt Repaid | -2.30B | -2.48B | -2.21B | -2.16B | -533.20M |
Issuance of Common Stock | -- | -- | -- | -- | -- |
Repurchase of Common Stock | -8.20M | -8.30M | -7.00M | -7.30M | -4.60M |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -21.80M | -21.50M | -19.50M | -17.90M | 1.90M |
Cash from Financing | -249.30M | -335.30M | -318.00M | -303.20M | -230.50M |
Foreign Exchange rate Adjustments | -13.40M | -22.90M | 2.20M | -11.50M | -6.50M |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -61.50M | -157.40M | -98.10M | -158.00M | -49.30M |